These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10541867)

  • 21. [A trend of molecular genetics on prion diseases and prion protein].
    Muramatsu Y; Shinagawa M
    Nihon Rinsho; 1993 Sep; 51(9):2494-502. PubMed ID: 8411733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accumulation of prion protein in the peripheral nervous system in human prion diseases.
    Lee CC; Kuo LT; Wang CH; Scaravilli F; An SF
    J Neuropathol Exp Neurol; 2005 Aug; 64(8):716-21. PubMed ID: 16106220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA; Telling GC
    Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gerstmann-Sträussler-Scheinker syndrome,fatal familial insomnia, and kuru: a review of these less common human transmissible spongiform encephalopathies.
    Collins S; McLean CA; Masters CL
    J Clin Neurosci; 2001 Sep; 8(5):387-97. PubMed ID: 11535002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prion protein and the transmissible spongiform encephalopathies.
    Caughey B; Chesebro B
    Trends Cell Biol; 1997 Feb; 7(2):56-62. PubMed ID: 17708907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prion diseases: current understanding of epidemiology and pathogenesis, and therapeutic advances.
    Caramelli M; Ru G; Acutis P; Forloni G
    CNS Drugs; 2006; 20(1):15-28. PubMed ID: 16396521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A special report I. Prion protein (PrP)--amyloid plaques in the transmissible spongiform encephalopathies, or prion diseases revisited.
    Liberski PP; Bratosiewicz J; Waliś A; Kordek R; Jeffrey M; Brown P
    Folia Neuropathol; 2001; 39(4):217-35. PubMed ID: 11928893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acquired human prion diseases--past and present issues].
    Hagiwara K; Yamakawa Y; Hanada K
    Uirusu; 2009 Dec; 59(2):155-65. PubMed ID: 20218324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical detection of disease-associated prion protein in the peripheral nervous system in experimental H-type bovine spongiform encephalopathy.
    Okada H; Iwamaru Y; Yokoyama T; Mohri S
    Vet Pathol; 2013 Jul; 50(4):659-63. PubMed ID: 23269348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards authentic transgenic mouse models of heritable PrP prion diseases.
    Watts JC; Giles K; Bourkas ME; Patel S; Oehler A; Gavidia M; Bhardwaj S; Lee J; Prusiner SB
    Acta Neuropathol; 2016 Oct; 132(4):593-610. PubMed ID: 27350609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Human transmissible subacute spongiform encephalopathy].
    Dormont D
    Bull Acad Natl Med; 1994 May; 178(5):887-903; discussion 904-5. PubMed ID: 7953896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmissible spongiform encephalopathies in humans.
    Belay ED
    Annu Rev Microbiol; 1999; 53():283-314. PubMed ID: 10547693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prion protein (PrP) deposits in the tectum of experimental Gerstmann-Sträussler-Scheinker disease following intraocular inoculation.
    Liberski PP; Hainfellner JA; Sikorska B; Budka H
    Folia Neuropathol; 2012; 50(1):85-8. PubMed ID: 22505367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical localization of 14.3.3 zeta protein in amyloid plaques in human spongiform encephalopathies.
    Richard M; Biacabe AG; Streichenberger N; Ironside JW; Mohr M; Kopp N; Perret-Liaudet A
    Acta Neuropathol; 2003 Mar; 105(3):296-302. PubMed ID: 12557018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human prion diseases: surgical lessons learned from iatrogenic prion transmission.
    Bonda DJ; Manjila S; Mehndiratta P; Khan F; Miller BR; Onwuzulike K; Puoti G; Cohen ML; Schonberger LB; Cali I
    Neurosurg Focus; 2016 Jul; 41(1):E10. PubMed ID: 27364252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone.
    Cali I; Miller CJ; Parisi JE; Geschwind MD; Gambetti P; Schonberger LB
    Acta Neuropathol Commun; 2015 Jun; 3():37. PubMed ID: 26108478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biology of non-conventional transmissible agents or prions].
    Dormont D
    Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colocalization of prion protein and beta protein in the same amyloid plaques in patients with Gerstmann-Sträussler syndrome.
    Miyazono M; Kitamoto T; Iwaki T; Tateishi J
    Acta Neuropathol; 1992; 83(4):333-9. PubMed ID: 1349451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of a new infectious recombinant prion: a model to understand Gerstmann-Sträussler-Scheinker syndrome.
    Elezgarai SR; Fernández-Borges N; Eraña H; Sevillano AM; Charco JM; Harrathi C; Saá P; Gil D; Kong Q; Requena JR; Andréoletti O; Castilla J
    Sci Rep; 2017 Aug; 7(1):9584. PubMed ID: 28851967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.